✦ LIBER ✦

Pharmacokinetics/Pharmacodynamics of Y-700, a Novel Xanthine Oxidase Inhibitor, in Rats and Man

✍ Scribed by I. Yamada; A. Fukunari; T. Osajima; M. Kamezawa; H. Mori; J. Iwane

Publisher: John Wiley and Sons
Year: 2005
Weight: 8 KB
Volume: 36
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200509210

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

For Abstract see ChemInform Abstract in Full Text.

📜 SIMILAR VOLUMES

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Febuxostat (TMX-67), a Non-Purine Selective Inhibitor of Xanthine Oxidase/Xanthine Dehydrogenase (NPSIXO) in Patients with Gout and/or Hyperuricemia

✍ K. Komoriya; S. Hoshide; K. Takeda; H. Kobayashi; J. Kubo; M. Tsuchimoto; T. Nak 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 9 KB 👁 1 views

Pharmacokinetics of a novel histone deac

Pharmacokinetics of a novel histone deacetylase inhibitor, apicidin, in rats

✍ Beom Soo Shin; Hyun Sook Chang; Eun Hye Park; Chi Ho Yoon; Hye Youn Kim; John Ki 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Pharmacokinetics of a novel antiangiogen

Pharmacokinetics of a novel antiangiogenic agent KR-31831 in rats

✍ Sook J. Kim; Hong I. Lee; Hye Y. Ji; Ya Moon; In B. Paek; Sunkyung Lee; Kyu Y. Y 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

Febuxostat (TMX-67), a Novel, Non-Purine

Febuxostat (TMX-67), a Novel, Non-Purine, Selective Inhibitor of Xanthine Oxidase, Is Safe and Decreases Serum Urate in Healthy Volunteers

✍ M. A. Becker; J. Kisicki; R. Khosravan; J. Wu; D. Mulford; B. Hunt; P. MacDonald 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Pharmacokinetics of a novel surface-acti

Pharmacokinetics of a novel surface-active agent, purified poloxamer 188, in rat, rabbit, dog and man

✍ J. Michael Grindel; Ted Jaworski; R. Martin Emanuele; Paula Culbreth 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

Disposition and pharmacokinetics of L-N6

Disposition and pharmacokinetics of L-N6-(1-iminoethyl)lysine-5-tetrazole-amide, a selective iNOS inhibitor, in rats

✍ Ji Y. Zhang; Yuefen Wang; Mark N. Milton; Lori Kraus; Alan P. Breau; Susan K. Pa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

The metabolism, pharmacokinetics, tissue distribution, and excretion of L-N6-(1-iminoethyl)lysine-5-tetrazole-amide (L-NIL-TA), a selective inducible NO synthase (iNOS) inhibitor, were investigated in rats. [ 14 C]L-NIL-TA is extensively metabolized after either oral or IV administration with a mino